Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription 06.05.2024 1 Am Heart J 3 Am J Cardiol 3 Atherosclerosis 2 Biochem Biophys Res Commun 1 BMC Pediatr 2 BMJ 1 Diabet Med 2 Diabetes 3 Diabetes Care 13 Diabetes Obes Metab 3 Diabetologia 1 Eur J Endocrinol 1 J Am Soc Nephrol 3 J Clin Endocrinol Metab 4 J Diabetes Complications 1 Kidney Int 8 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. GAGNON LR, Hazra D, Perera K, Wang K, et al
   Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort.
   Am Heart J. 2024 Apr 24:S0002-8703(24)00094-2. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. GOKHALE KM, Chandan JS, Sainsbury C, Tino P, et al
   Using Repeated Measurements to Predict Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
   Am J Cardiol. 2024;210:133-142.
   PubMed         Abstract available
   
   
3. CORDERO A, Sirera D, Mendez-Gallego J, Echeverria I, et al
   Effect of diabetes mellitus on global longitudinal strain.
   Am J Cardiol. 2024 Apr 26:S0002-9149(24)00281.
   PubMed        
   
   
4. MOIZ A, Levett JY, Filion KB, Peri K, et al
   Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
   Am J Cardiol. 2024 Apr 26:S0002-9149(24)00319.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

5. DARDANO A, Bianchi C, Garofolo M, Del Prato S, et al
   The current landscape for diabetes treatment: Preventing diabetes-associated CV risk.
   Atherosclerosis. 2024 Apr 23:117560. doi: 10.1016/j.atherosclerosis.2024.117560.
   PubMed         Abstract available
   
   
6. LUCIANI L, Pedrelli M, Parini P
   Modification of lipoprotein metabolism and function driving atherogenesis in diabetes.
   Atherosclerosis. 2024 Apr 17:117545. doi: 10.1016/j.atherosclerosis.2024.117545.
   PubMed         Abstract available
   
   
7. ARSENAULT BJ, Carpentier AC, Poirier P, Despres JP, et al
   Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index.
   Atherosclerosis. 2024 Apr 14:117546. doi: 10.1016/j.atherosclerosis.2024.117546.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

8. MEI X, Li Y, Wu J, Liao L, et al
   Dulaglutide restores endothelial progenitor cell levels in diabetic mice and mitigates high glucose-induced endothelial injury through SIRT1-mediated mitochondrial fission.
   Biochem Biophys Res Commun. 2024;716:150002.
   PubMed         Abstract available
   
   
9. ZHOU L, Dong M, Feng G, Zhang Y, et al
   Semaglutide mitigates testicular damage in diabetes by inhibiting ferroptosis.
   Biochem Biophys Res Commun. 2024;715:149996.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

10. AMIRI N, Karami K, Valizadeh F, Mokhayeri Y, et al
    The effect of exercise on sleep habits of children with type 1 diabetic: a randomized clinical trial.
    BMC Pediatr. 2024;24:283.
    PubMed         Abstract available
    
    

    
    BMJ

11. PASTERNAK B, Wintzell V, Hviid A, Eliasson B, et al
    Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    BMJ. 2024;385:e078225.
    PubMed         Abstract available
    
    
12. MAHASE E
    Diabetes UK defends partnership with Slimming World in face of criticism.
    BMJ. 2024;385:q962.
    PubMed        
    
    

    
    Diabet Med

13. RUSSELL-JONES D, Bailey TS, Lane W, Mathieu C, et al
    Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative review.
    Diabet Med. 2024 Apr 28:e15339. doi: 10.1111/dme.15339.
    PubMed         Abstract available
    
    

    
    Diabetes

14. FRORUP C, Jensen MH, Haupt-Jorgensen M, Buschard K, et al
    Elevated cathepsin S serum levels in new-onset type 1 diabetes and autoantibody-positive siblings.
    Diabetes. 2024 May 3:db230911. doi: 10.2337/db23-0911.
    PubMed         Abstract available
    
    
15. CHOUCAIR I, Mallela DP, Hilser JR, Hartiala JA, et al
    Comprehensive clinical and genetic analyses of circulating bile acids and their associations with diabetes and its indices.
    Diabetes. 2024 May 3:db230676. doi: 10.2337/db23-0676.
    PubMed         Abstract available
    
    

    
    Diabetes Care

16. DURNWALD C, Beck RW, Li Z, Norton E, et al
    Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus.
    Diabetes Care. 2024 May 3:dc232149. doi: 10.2337/dc23-2149.
    PubMed         Abstract available
    
    
17. 
    Erratum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care 2024;47(Suppl. 1):S158-S178.
    Diabetes Care. 2024 May 2:dc24er07a. doi: 10.2337.
    PubMed         Abstract available
    
    
18. CRISTELLO SARTEAU A, Ercolino G, Muthukkumar R, Fruik A, et al
    Nutritional Status, Dietary Intake, and Nutrition-Related Interventions Among Older Adults With Type 1 Diabetes: A Systematic Review and Call for More Evidence Toward Clinical Guidelines.
    Diabetes Care. 2024 Apr 30:dci230099. doi: 10.2337/dci23-0099.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

19. SMATI S, Sotin T, Deniel P, Ducheix S, et al
    Empagliflozin mitigates metabolic dysfunction-associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetes.
    Diabetes Obes Metab. 2024 May 3. doi: 10.1111/dom.15634.
    PubMed        
    
    
20. TIRADO-AGUILAR OA, Martinez-Cruz N, Arce-Sanchez L, Borboa-Olivares H, et al
    Earlier detection of gestational diabetes impacts on medication requirements, neonatal and maternal outcomes.
    Diabetes Obes Metab. 2024 May 3. doi: 10.1111/dom.15633.
    PubMed         Abstract available
    
    
21. XIANG C, Sun Y, Luo Y, Xie C, et al
    Gastric emptying is slower in women than men with type 2 diabetes and impacts on postprandial glycaemia.
    Diabetes Obes Metab. 2024 May 2. doi: 10.1111/dom.15635.
    PubMed         Abstract available
    
    
22. SUN Y, Luo Y, Xiang C, Xie C, et al
    Gastric emptying in newly diagnosed, treatment-naive Han Chinese with type 2 diabetes and the impact of 4-week insulin pump therapy.
    Diabetes Obes Metab. 2024 May 2. doi: 10.1111/dom.15626.
    PubMed         Abstract available
    
    
23. CHEN J, Li YT, Niu Z, He Z, et al
    Investigating the causal association of generalized and abdominal obesity with microvascular complications in patients with type 2 diabetes: A community-based prospective study.
    Diabetes Obes Metab. 2024 May 2. doi: 10.1111/dom.15598.
    PubMed         Abstract available
    
    
24. LI S, Pan S, Jiang S, Shin JI, et al
    Prescription medication use among patients with type 2 diabetes in the United States: 1999-2020.
    Diabetes Obes Metab. 2024 May 2. doi: 10.1111/dom.15619.
    PubMed         Abstract available
    
    
25. SU J, Fan X, Li M, Yu H, et al
    Association of lifestyle with reduced stroke risk in 41 314 individuals with diabetes: Two prospective cohort studies in China.
    Diabetes Obes Metab. 2024 Apr 29. doi: 10.1111/dom.15606.
    PubMed         Abstract available
    
    
26. SEUFERT J, Freemantle N, Guja C, Haluzik M, et al
    Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use.
    Diabetes Obes Metab. 2024 Apr 29. doi: 10.1111/dom.15609.
    PubMed        
    
    
27. NAKHLEH A, Abdul-Ghani M, Gazit S, Gross A, et al
    Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.
    Diabetes Obes Metab. 2024 Apr 28. doi: 10.1111/dom.15623.
    PubMed         Abstract available
    
    
28. MICHALOPOULOU M, Piernas C, Jebb SA, Gao M, et al
    Association of gestational diabetes with long-term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank.
    Diabetes Obes Metab. 2024 Apr 28. doi: 10.1111/dom.15612.
    PubMed         Abstract available
    
    
29. REED J, Dong T, Eaton E, Friswold J, et al
    Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
    Diabetes Obes Metab. 2024 Apr 28. doi: 10.1111/dom.15608.
    PubMed         Abstract available
    
    
30. YANG M, Yue H, Xu Q, Shao S, et al
    Pioglitazone reduces serum ketone bodies in sodium-glucose cotransporter-2 inhibitor-treated non-obese type 2 diabetes: A single-centre, randomized, crossover trial.
    Diabetes Obes Metab. 2024 May 3. doi: 10.1111/dom.15641.
    PubMed         Abstract available
    
    
31. TAKAHASHI A, Nomoto H, Onishi K, Manda S, et al
    A comparative study of the effects of imeglimin add-on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low-dose metformin (MEGMI-CGM study).
    Diabetes Obes Metab. 2024 May 3. doi: 10.1111/dom.15639.
    PubMed        
    
    

    
    Diabetologia

32. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Apr 30. doi: 10.1007/s00125-024-06135.
    PubMed        
    
    
33. TREVISAN R, Conti M, Ciardullo S
    Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
    Diabetologia. 2024 Apr 29. doi: 10.1007/s00125-024-06158.
    PubMed         Abstract available
    
    
34. CHEN J, Feng Q, Qiao Y, Pan S, et al
    ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes.
    Diabetologia. 2024 Apr 27. doi: 10.1007/s00125-024-06156.
    PubMed         Abstract available
    
    

    
    Eur J Endocrinol

35. FUHRI SNETHLAGE CM, Meijnikman AS, Mak AL, Rampanelli E, et al
    Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
    Eur J Endocrinol. 2024 Apr 29:lvae043. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

36. DOKE T, Bjornstad P
    Endothelial-Mesenchymal Transition Switch and Diabetic Kidney Disease.
    J Am Soc Nephrol. 2024 May 3. doi: 10.1681/ASN.0000000000000364.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

37. LING P, Yang D, Wang C, Zheng X, et al
    Basal Hyperglycemia Contributes More Than Fifty Percent to Time in Range in Pregnant Women with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 30:dgae291. doi: 10.1210.
    PubMed         Abstract available
    
    
38. LIN X, Zhu K, Qiu Z, Li R, et al
    Associations Between Beverage Consumption and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 12:dgae242. doi: 10.1210.
    PubMed         Abstract available
    
    
39. SCAIRATI R, Auriemma RS, Di Meglio S, Del Vecchio G, et al
    Risk Assessment of Diabetes Mellitus during and after Pregnancy in Women with Prolactinomas.
    J Clin Endocrinol Metab. 2024 May 2:dgae289. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

40. YAMADA E, Kajita R, Takahashi H, Horiguchi K, et al
    Exploring potential correlations between HLA class II and the risk of microvascular complications in Japanese patients with type 1 diabetes.
    J Diabetes Complications. 2024;38:108763.
    PubMed         Abstract available
    
    
41. MIZRAK HI, Kufaishi H, Hecquet SK, Hansen TW, et al
    Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic.
    J Diabetes Complications. 2024;38:108761.
    PubMed         Abstract available
    
    
42. XIE W, Hong Z, Li B, Huang B, et al
    Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials.
    J Diabetes Complications. 2024;38:108743.
    PubMed         Abstract available
    
    
43. BOOKER R, Wong M, Bancks MP, Carnethon MR, et al
    The longitudinal association of adipose-to-lean ratio with incident cardiometabolic morbidity: The CARDIA study.
    J Diabetes Complications. 2024;38:108725.
    PubMed         Abstract available
    
    

    
    Kidney Int

44. MURPHY DP, Wolfson J, Reule S, Johansen KL, et al
    A cohort study of sodium-glucose cotransporter-2 inhibitors after acute kidney injury among Veterans with diabetic kidney disease.
    Kidney Int. 2024 Apr 27:S0085-2538(24)00309-0. doi: 10.1016/j.kint.2024.
    PubMed         Abstract available
    
    

    
    PLoS One

45. LIN YH, Zhang ZJ, Zhong JQ, Wang ZY, et al
    Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0302155.
    PubMed         Abstract available
    
    
46. DE RIDDER F, Braspenning R, Ordonez JS, Klarenbeek G, et al
    Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanol.
    PLoS One. 2024;19:e0301041.
    PubMed         Abstract available
    
    
47. TRIPATHI P, Kadam N, Tiwari D, Vyawahare A, et al
    Oral glucose tolerance test clearance in type 2 diabetes patients who underwent remission following intense lifestyle modification: A quasi-experimental study.
    PLoS One. 2024;19:e0302777.
    PubMed         Abstract available
    
    
48. LI W, She L, Zhang M, Yang M, et al
    The associations of IGF2, IGF2R and IGF2BP2 gene polymorphisms with gestational diabetes mellitus: A case-control study.
    PLoS One. 2024;19:e0298063.
    PubMed         Abstract available
    
    
49. LIU YC, Chung CH, Lin CJ, Su SC, et al
    The role of traditional Chinese medicine on fracture surgery, hospitalization, and total mortality risks in diabetic patients with osteoporosis.
    PLoS One. 2024;19:e0289455.
    PubMed         Abstract available
    
    
50. LI T, Geng L, Yang Y, Liu G, et al
    Protective effect of phospholipids in lipoproteins against diabetic kidney disease: A Mendelian randomization analysis.
    PLoS One. 2024;19:e0302485.
    PubMed         Abstract available
    
    
51. STOCKMARR A, Frolich A
    Clusters from chronic conditions in the Danish adult population.
    PLoS One. 2024;19:e0302535.
    PubMed         Abstract available
    
    
52. NEWAIRY AA, Hamaad FA, Wahby MM, Ghoneum M, et al
    Neurotherapeutic effects of quercetin-loaded nanoparticles and Biochanin-A extracted from Trifolium alexandrinum on PI3K/Akt/GSK-3beta signaling in the cerebral cortex of male diabetic rats.
    PLoS One. 2024;19:e0301355.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.